Learn how zavegepant, the first intranasal CGRP receptor antagonist, offers fast-acting, targeted relief for acute migraine—especially for patients who can’t tolerate oral medications or need rapid onset of action.
- admin@condrug.com
- Mon - Sat: 8.00 am - 7.00 pm
We develop solutions for your clinical data needs